Oxygen 30 %

DRUG2 trials

Sponsors

Medical University of Vienna, Negovsky Reanimatology Research Institute

Conditions

Brain Natriuretic PeptideCardiac Risk PatientsIschemic StrokePerioperativeSupplemental Oxygen

Phase 3

Neuroprotective Effects of Xenon Treatment in Patients with Cerebral Infarction

CompletedNCT05335109

Negovsky Reanimatology Research InstituteIschemic Stroke

Start: 2022-01-01End: 2024-01-15Updated: 2024-10-03

Phase 4

Effect of Supplemental Oxygen on Perioperative BNP Concentration in Cardiac Risk Patients

CompletedNCT03366857

Medical University of ViennaBrain Natriuretic Peptide, Cardiac Risk Patients, Perioperative +1

Start: 2017-12-01End: 2020-05-30Updated: 2020-06-11

Related Papers

Hemodynamic effects of intraoperative 30% versus 80% oxygen concentrations: an exploratory analysis

Frontiers in Medicine2023-05-30

Perioperative supplemental oxygen and oxidative stress in patients undergoing moderate- to high-risk major abdominal surgery – A subanalysis of randomized clinical trial

Journal of Clinical Anesthesia2021-11-299 citations

Perioperative supplemental oxygen and NT-proBNP concentrations after major abdominal surgery – A prospective randomized clinical trial

Journal of Clinical Anesthesia2021-06-0133 citations

The effect of supplemental oxygen on perioperative brain natriuretic peptide concentration in cardiac risk patients - a protocol for a prosprective randomized clinical trial.

2020-05-128 citations